NBTY To Web Cast Presentation at Morgan Stanley Conference - Announces Preliminary Unaudited Net Sales Results For May 2006 -
13 6월 2006 - 10:00PM
PR Newswire (US)
BOHEMIA, N.Y., June 13 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced that it
will web cast the presentation by Harvey Kamil, President and Chief
Financial Officer of NBTY, at the Morgan Stanley Small Cap
Executive Conference in New York on Thursday, June 15, 2006. The
conference is being held at the Crowne Plaza Hotel in New York. The
presentation is scheduled to be web cast live on the Company Web
site, http://www.nbty.com/ on Thursday, June 15, 2006 at 8:00 AM
Eastern Time. NBTY's preliminary unaudited net sales results for
May 2006 and for the two months then ended by segment are as
follows: NET SALES (Preliminary and Unaudited) FOR THE MONTH OF MAY
($ In Millions) 2006 2005 % Change Wholesale/ US Nutrition $79 $66
20% North American Retail / Vitamin World $19 $19 -1% European
Retail / Holland & Barrett / GNC (UK) $49 $ 48 3% Direct
Response/ Puritan's Pride $18 $21 -13% Total $ 165 $154 7% The
above May 2006 net sales include net sales of $7 million from
Solgar and $1 million from SISU. European retail net sales in local
currency increased 3% in May 2006. NBTY's preliminary unaudited net
sales results for the two months April and May 2006 and 2005
respectively by segment are as follows: NET SALES (Preliminary and
Unaudited) FOR THE TWO MONTHS APRIL AND MAY ($ In Millions) 2006
2005 % Change Wholesale/ US Nutrition $ 157 $129 22% North American
Retail / Vitamin World $40 $40 0% European Retail / Holland &
Barrett / GNC (UK) $93 $ 99 -6% Direct Response/ Puritan's Pride
$33 $37 -10% Total $ 324 $305 6% The above April and May 2006 net
sales include net sales of $17 million from Solgar and $2 million
from SISU. European retail net sales in local currency decreased 3%
for the two month period of April and May 2006. ABOUT NBTY NBTY is
a leading vertically integrated manufacturer, marketer and
distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. Under a number of NBTY and third party brands, the Company
offers over 22,000 products, including products marketed by the
Company's Nature's Bounty(R), Vitamin World(R), Puritan's Pride(R),
Holland & Barrett(R), Rexall(R), Sundown(R), MET-Rx(R),
WORLDWIDE Sport Nutrition(R), American Health(R), GNC (UK)(R),
DeTuinen(R), LeNaturiste(TM), SISU(R) and Solgar(R) brands. This
release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
with respect to our financial condition, results of operations and
business. These forward-looking statements can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"plan," "project," "estimate," "intend," "may," "will," "should,"
"can," or "anticipates," or the negative thereof, or variations
thereon, or comparable terminology, or by discussions of strategy.
Although all of these forward-looking statements are believed to be
reasonable, they are inherently uncertain. Factors which may
materially affect such forward-looking statements include: (i) slow
or negative growth in the nutritional supplement industry; (ii)
interruption of business or negative impact on sales and earnings
due to acts of God, acts of war, terrorism, bio- terrorism, civil
unrest or disruption of mail service; (iii) adverse publicity
regarding nutritional supplements; (iv) inability to retain
customers of companies (or mailing lists) recently acquired; (v)
increased competition; (vi) increased costs; (vii) loss or
retirement of key members of management; (viii) increases in the
cost of borrowings and/or unavailability of additional debt or
equity capital; (ix) unavailability of, or inability to consummate,
advantageous acquisitions in the future, including those that may
be subject to bankruptcy approval or the inability of NBTY to
integrate acquisitions into the mainstream of its business; (x)
changes in general worldwide economic and political conditions in
the markets in which NBTY may compete from time to time; (xi) the
inability of NBTY to gain and/or hold market share of its wholesale
and/or retail customers anywhere in the world; (xii) unavailability
of electricity in certain geographical areas; (xiii) the inability
of NBTY to obtain and/or renew insurance and/or the costs of the
same; (xiv) exposure to and expense of defending and resolving
product liability and intellectual property claims and other
litigation; (xv) the ability of NBTY to successfully implement its
business strategy; (xvi) the inability of NBTY to manage its
retail, wholesale, manufacturing and other operations efficiently;
(xvii) consumer acceptance of NBTY's products; (xviii) the
inability of NBTY to renew leases for its retail locations; (xix)
the inability of NBTY's retail stores to attain or maintain
profitability; (xx) the absence of clinical trials for many of
NBTY's products; (xxi) sales and earnings volatility and/or trends
for the Company and its market segments; (xxii) the efficacy of
NBTY's Internet and on-line sales and marketing strategies; (xxiii)
fluctuations in foreign currencies, including the British Pound,
the Euro and the Canadian dollar; (xxiv) import-export controls on
sales to foreign countries; (xxv) the inability of NBTY to secure
favorable new sites for, and delays in opening, new retail
locations; (xxvi) introduction of and compliance with new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly proposed Good
Manufacturing Practices in the United States, the Food Supplements
Directive and Traditional Herbal Medicinal Products Directive in
Europe and Section 404 requirements of the Sarbanes-Oxley Act of
2002; (xxvii) the mix of NBTY's products and the profit margins
thereon; (xxviii) the availability and pricing of raw materials;
(xxix) risk factors discussed in NBTY's filings with the U.S.
Securities and Exchange Commission; (xxx) adverse effects on NBTY
as a result of increased gasoline prices and potentially reduced
traffic flow to NBTY's retail locations; (xxxi) adverse tax
determinations; (xxxii) the loss of a significant customer of the
Company; and (xxxiii) other factors beyond the Company's control.
Readers are cautioned not to place undue reliance on
forward-looking statements. NBTY cannot guarantee future results,
trends, events, levels of activity, performance or achievements.
NBTY does not undertake and specifically declines any obligation to
update, republish or revise forward- looking statements to reflect
events or circumstances after the date hereof or to reflect the
occurrences of unanticipated events. Consequently, such
forward-looking statements should be regarded solely as NBTY's
current plans, estimates and beliefs. Contact: Harvey Kamil Carl
Hymans NBTY, Inc. G.S. Schwartz & Co. President & Chief
Financial Officer 212-725-4500 631-200-2020 DATASOURCE: NBTY, Inc.
CONTACT: Harvey Kamil, President & Chief Financial Officer of
NBTY, Inc., +1-631-200-2020; or Carl Hymans of G.S. Schwartz &
Co., +1-212-725-4500, Web site: http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024